Healthcare provider profile · identity verified

Mohammad H Osmani, MD

Internal Medicine · REDLANDS, CA · NPI 1568479483

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	532	154
Levothyroxine Sodium	Levothyroxine Sodium	314	73
Amlodipine Besylate	Amlodipine Besylate	309	74
Metformin Hcl	Metformin Hcl	308	79
Metoprolol Succinate	Metoprolol Succinate	305	82
Tamsulosin Hcl	Tamsulosin Hcl	275	67
Pantoprazole Sodium	Pantoprazole Sodium	258	59
Losartan Potassium	Losartan Potassium	256	75
Omeprazole	Omeprazole	236	61
Furosemide	Furosemide	235	66
Potassium Chloride	Potassium Chloride	211	57
Gabapentin	Gabapentin	203	51
Albuterol Sulfate Hfa	Albuterol Sulfate	202	56
Escitalopram Oxalate	Escitalopram Oxalate	195	48
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	193	54
Meloxicam	Meloxicam	193	55
Lisinopril	Lisinopril	159	54
Triamcinolone Acetonide	Triamcinolone Acetonide	158	46
Fluticasone Propionate	Fluticasone Propionate	139	49
Simvastatin	Simvastatin	139	36
Eliquis	Apixaban	134	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	114	27
Glipizide	Glipizide	101	29
Nifedipine Er	Nifedipine	100	25
Duloxetine Hcl	Duloxetine Hcl	97	24
Jardiance	Empagliflozin	97	16
Carvedilol	Carvedilol	96	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	96	67
Diclofenac Sodium	Diclofenac Sodium	96	29
Alprazolam	Alprazolam	91	24
Zolpidem Tartrate	Zolpidem Tartrate	91	15
Donepezil Hcl	Donepezil Hcl	90	20
Famotidine	Famotidine	87	27
Baclofen	Baclofen	86	24
Sertraline Hcl	Sertraline Hcl	85	19
Ibuprofen	Ibuprofen	84	29
Naproxen	Naproxen	80	26
Atenolol	Atenolol	78	20
Hydrochlorothiazide	Hydrochlorothiazide	78	23
Rosuvastatin Calcium	Rosuvastatin Calcium	78	25
Metoprolol Tartrate	Metoprolol Tartrate	77	20
Memantine Hcl	Memantine Hcl	70	13
Pravastatin Sodium	Pravastatin Sodium	70	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	64	56
Nystatin	Nystatin	62	24
Pregabalin	Pregabalin	62	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	suppressed
Trazodone Hcl	Trazodone Hcl	60	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	55	17
Tramadol Hcl	Tramadol Hcl	55	20
Bupropion Xl	Bupropion Hcl	54	suppressed
Meclizine Hcl	Meclizine Hcl	54	25
Alendronate Sodium	Alendronate Sodium	53	13
Aripiprazole	Aripiprazole	53	11
Olmesartan Medoxomil	Olmesartan Medoxomil	52	15
Wixela Inhub	Fluticasone Propion/Salmeterol	52	13
Finasteride	Finasteride	51	14
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Temazepam	Temazepam	47	suppressed
Paroxetine Hcl	Paroxetine Hcl	45	11
Pioglitazone Hcl	Pioglitazone Hcl	45	12
Clonidine Hcl	Clonidine Hcl	44	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	15
Januvia	Sitagliptin Phosphate	42	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Mirtazapine	Mirtazapine	41	suppressed
Celecoxib	Celecoxib	39	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	12
Glipizide Er	Glipizide	34	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	34	suppressed
Allopurinol	Allopurinol	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	32	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Prednisone	Prednisone	31	22
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Folic Acid	Folic Acid	30	suppressed
Myrbetriq	Mirabegron	30	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	14
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Cephalexin	Cephalexin	25	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Dutasteride	Dutasteride	25	suppressed
Levofloxacin	Levofloxacin	25	22
Metronidazole	Metronidazole	25	13
Synthroid	Levothyroxine Sodium	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Nitroglycerin	Nitroglycerin	21	12
Xarelto	Rivaroxaban	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Humalog Kwikpen U-200	Insulin Lispro	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Ozempic	Semaglutide	19	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	18	suppressed
Digoxin	Digoxin	18	suppressed
Procto-Med Hc	Hydrocortisone	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	17
Farxiga	Dapagliflozin Propanediol	17	suppressed
Hydrocortisone	Hydrocortisone	17	11
Irbesartan	Irbesartan	17	suppressed
Klor-Con 10	Potassium Chloride	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Risperidone	Risperidone	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Sulfasalazine	Sulfasalazine	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Mesalamine Dr	Mesalamine	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Azelastine Hcl	Azelastine Hcl	12	suppressed
Azithromycin	Azithromycin	12	11
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Diazepam	Diazepam	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Indomethacin	Indomethacin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error